Wound Care Professional的动态

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have emerged as a pivotal class of #medications in the treatment of?#heart failure?(HF). Their ability to reduce #hospitalization and mortality has significantly impacted patient outcomes. Despite this, challenges persist in optimizing #SGLT2i utilization, particularly in #inpatient settings. A collection of abstracts presented at the Heart Failure Society of America 2024 Annual Meeting delved into these challenges and explored the #benefits of SGLT2i in the #patient population. https://lnkd.in/eEcN-hn5

In a retrospective analysis sponsored by AtriCure, healthcare systems saved an average of $8,601 in total healthcare costs for lobectomy patients who received Cryo Nerve Block (ablation) for post-op pain management compared to those who did not. Learn more about the device reducing hospital system costs and relieving post-op pain at: https://okt.to/auKl0L

The Power of Blood Component Therapy: Unlocking Medical Advancements Discover the revolutionary approach to blood transfusion medicine. Learn how single units of blood can be split into multiple components to cater to specific medical needs. Join us as we delve into the benefits and advancements of blood component therapy. #BloodComponentTherapy #MedicalAdvancements #TransfusionMedicine #MedicalBreakthroughs #BloodDonation #Healthcare #MedicalResearch #PatientCare #MedicalInnovation #HealthTech

Explore how the BASHIR? .035 Endovascular Catheter empowers physicians to safely and quickly treat pulmonary embolism. Clinically proven safety and efficacy combined with an 8F easy to place catheter reduces procedure time and resolves pulmonary obstruction. Learn more about this innovative technology at Thrombolex.com #Thrombolex

Can you imagine how a constant itch would impact the things you enjoy? In your haemodialysis patients, CKD-associated Pruritus (CKD-aP) may be much more than just an itch. Learn more: https://ckd-ap.com

Solutions.Webinar: Sponsored by bioMerieux | Syndomic Testing: Empowering Clinical Decisions Through Rapid, PCR Results ? Webinar: Thursday, June 13 | 1 p.m. CT Listen as experts share how they use rapid diagnostics to make informed decisions and elevate the patient experience. ? - Understand the current challenges in the Urgent Care setting. - Discuss factors that impact the patient and clinician experience. - Describe syndromic testing and the impact it can have on patient care. - Explore innovative solutions to boost efficiency this respiratory season. https://lnkd.in/erGdRmyf

Dialysis Clinic Managers: Are you ready to cut thrombosis rates in half? Data doesn’t lie—clinics utilizing Vasc-Alert’s automated intravascular access pressure surveillance saw thrombosis rates drop by 55% over an 18-month intervention. Whether you're managing arteriovenous grafts (AVG) or fistulas (AVF), this innovative solution ensures earlier detection of access issues, reducing complications and improving patient outcomes. With sensitivity as high as 92% for detecting adverse events, Vasc-Alert is not just a monitoring tool—it’s a game-changer for proactive dialysis care. Ready to see the impact for yourself? Schedule a demo today and take the first step toward more efficient, patient-centered care. #DialysisCare #ThrombosisPrevention #VascularAccess #PatientSafety

At the European Renal Association #ERA24 congress taking place this week, newly published data are shedding light on the importance of following guideline-directed medical therapy in cardiorenal patients with hyperkalaemia (HK).?? ? We know that HK is manageable, and hospitalisations are avoidable when treated as a chronic condition. However, patients with HK often see their renin‐angiotensin‐aldosterone system inhibitor (RAASi) medications reduced or even stopped, resulting in an increase in hospitalisations.?? ??? HK should not be a barrier to optimised care. We must work together to drive a deeper understanding of how to manage this condition in the long term.? ? Find out more here: https://lnkd.in/ddpYG6jF

Unlocking the full potential of home hemodialysis (HHD) requires a shift in how we approach dialysis care. A goal-driven strategy that prioritizes patient-centered, individualized treatment plans, showing how HHD can be more than just an alternative—it can help transform lives. As a company we continue to innovate in home dialysis, it’s important to remember the key to success: focusing on what matters most to patients. Read the full article to learn more about how goal-oriented care is helping more patients thrive: https://bit.ly/3I1iEmF